ETFs Are Net Sellers of Synopsys (SNPS) on Nov. 11

ETFs sold $10.1M of Synopsys (SNPS) on Nov. 11, extending a two-day selling streak. QQQ, DFAU, and IVV were top sellers. SNPS has a market cap of $88.7B, P/E of 81.73, and is down 1.5% YTD. GuruFocus flagged 5 warning signs for the company.

Original reporting
Published Nov 13, 2026, 11:02 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 13, 2026, 11:14 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
ETFs Are Net Sellers of Synopsys (SNPS) on Nov. 11 — source image
Decision brief

The 30-second read

$SNPSBearishLow
01

Why it matters

ETF outflows could temporarily depress SNPS price, but the effect is likely short‑lived given strong fundamentals.

02

Market read

ETF flow data provides a short‑term trading signal for SNPS but limited broader market relevance.

03

What to watch

The outflow is modest relative to SNPS market cap; underlying earnings growth remains robust.

Relevance 4/10Novelty 3/10Timing: Nov 11

Background

The article reports daily ETF activity for Synopsys, highlighting net sellers and buyers.

Company-level read

Ticker impact

$SNPSBearishMedium confidence
Context

ETFs sold $10.1 million of SNPS on Nov. 11, extending a two‑day selling streak.

Expected impact

likely pressure as the market prices in the ETF outflows

Evidence & confidence

Large ETFs such as QQQ, DFAU and IVV reduced holdings, indicating reduced demand.

Market effects

Minor impact on the broader software‑infrastructure sector as SNPS is a large cap player.

US equity market may see slight dip in technology ETFs holding SNPS.

Limited; the flow is US‑focused and does not affect global macro trends.

Counterpoint

ETF sellers may be rotating into other tech names, presenting a buying opportunity for SNPS if fundamentals remain strong.

Key entities

  • Synopsys

    Provider of electronic design automation software.

Related articles

$SNPSMed

Why is Synopsys stock sliding today?

Synopsys (SNPS) stock fell 2.0% to $456.73 after Anthropic's IPO roadshow highlighted AI-driven chip design, raising competition concerns. The stock has declined further from its 52-week high of $539.48, with One Way Holdings LLC reducing its position by 99%. Investors are evaluating Synopsys's valuation and integration risks amid broader market uncertainty.

$SNPSMed

Why Should You Think About Synopsys Differently Now?

Synopsys (SNPS) trades at 80.8x P/E, focusing on AI-driven chip design and Ansys. Its IP business, which underperformed due to export restrictions and customer challenges, returned to growth in Q3 2026. Ansys revenue was 1.5x Design IP's revenue in the same quarter. Management highlights a shift to a licensing-plus-royalties model, with a $1B+ deal with Amazon.

$SNPSMed

S&P lifts Synopsys to ’BBB+’ as chip-design leader capitalizes on AI demand

S&P Global Ratings upgraded Synopsys Inc's credit rating to 'BBB+' from 'BBB', citing strong long-term growth prospects driven by AI demand. The company expects mid-teens revenue growth through 2029 and improved profitability, with 2029 EBITDA margin projected at 49%. Synopsys is also accelerating cost synergies from its Ansys acquisition and expanding commercial traction, including a $1B+ contract with Amazon.

$AMZNMedAI 8/10

Amazon and Synopsys seal $1bn technology partnership

Amazon and Synopsys have signed a $1 billion deal to accelerate Amazon's custom silicon innovation and advance AI products and cloud infrastructure. The multi-year agreement builds on 15 years of collaboration, with Synopsys providing application-optimized silicon IP. Amazon's Peter DeSantis highlighted the impact of custom silicon on AWS, while Synopsys' Sassine Ghazi emphasized the partnership's role in shaping AI-native engineering.